feed,title,long_url,short_url
SeekingAlpha,CureVac shares drop 9% on final data from phase 2b/3 trial on COVID vaccine,https://seekingalpha.com/news/3711621,
SeekingAlpha,Passage Bio initiated overweight at Raymond James; expects a de-risking event this year,https://seekingalpha.com/news/3711620,
SeekingAlpha,Two Harbors Investment names new chief investment officer,https://seekingalpha.com/news/3711619,
